First-line treatments for advanced hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis in China and the United States.
Therap Adv Gastroenterol
; 15: 17562848221140662, 2022.
Article
en En
| MEDLINE
| ID: mdl-36518883
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Health_economic_evaluation
/
Systematic_reviews
Idioma:
En
Revista:
Therap Adv Gastroenterol
Año:
2022
Tipo del documento:
Article